RecruitingPhase 3NCT05835310
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Sponsor: AstraZeneca
New Hyde Park, NY · New York, NY · The Bronx, NY · +19 more sites
2 recruiting lupus studies with a site in New Hyde Park, NY.
Sponsor: AstraZeneca
New Hyde Park, NY · New York, NY · The Bronx, NY · +19 more sites
Sponsor: iCell Gene Therapeutics
Hawthorne, NY · New Hyde Park, NY · +2 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.